Update in thyroid imaging. the expanding world of thyroid imaging and its translation to clinical practice

Hormones

Volumn 9, Issue 4, 2010, Pages 287-298

  Soto, Gonzalo Díaz ^a   Halperin, Irene ^b   Squarcia, Mattia ^b   Lomeña, Francisco ^b   Domingo, Manuel Puig ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Fine needle aspiration biopsy; Positron emission tomography; Thyroid imaging; Thyroid nodules; Thyroid ultra sonography

Indexed keywords

IODINE 131; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ASPIRATION BIOPSY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; ELASTOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PALPATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID NODULE; THYROID SCINTISCANNING;

EID: 78649693855     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1279     Document Type: Review

References (58)

1. Mazzaferri EL, 1993 Management of a solitary thyroid nodule. N Engl J Med 328: 553-559.
2. Papini E, Guglielmi R, Bianchinia, et al, 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941-1946.
3. Nam-Goong IS, Kim HY, Gong G, et al, 2004 Ultra-sonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (oxf) 60: 21-28.
4. Sachmechi I, Miller E, Varatharajah R, et al, 2000 Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract 6: 5-7.
5. Rojeski MT, Gharib H, 1985 Nodular thyroid disease. Evaluation and management. N Engl J Med 313: 428-436.
6. Hamming JF, Goslings BM, van Steenis GJ, van Raven-Swaay Claasen H, Hermans J, van de Velde CJ, 1990 The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. arch Intern Med 150: 113-116.
7. Esen G, 2006 Ultrasound of superficial lymph nodes. Eur J Radiol 58: 345-359.
8. Bastin S, Bolland MJ, Croxson MS, 2009 Role of ultrasound in the assessment of nodular thyroid disease. J Med Imaging Radiat oncol 53: 177-187.
9. Hoang JK, Lee WK, Lee M, Johnson D, Farrell S, 2007 US Features of thyroid malignancy: pearls and pitfalls. Radiographics. 27: 847-865.
10. Rago T, Vitti P, 2008 Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22: 913-928.
11. Varverakis E, Neonakis E, 2002 Contribution of high-resolution ultrasonography in the differential diagnosis of benign from malignant thyroid nodules. Hormones (athens) 1: 51-56.
12. Gharib H, Papini E, Valcavi R, et al, 2006 American association of Clinical Endocrinologists and associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. EndocrPract 12: 63-102.
13. Frates MC, Benson CB, Charboneau JW, et al, 2006 Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 22: 231-238.
14. Cooper DS, Doherty GM, Haugen BR, et al, 2009 Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. thyroid 19: 1167-214.
15. Pacini F, Schlumberger M, Dralle H, et al, European thyroid Cancer taskforce, 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154: 787-803.
16. Ophir J, Céspedes I, Ponnekanti H, Yazdi Y, Li X, 1991 Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 13: 111-134.
17. Cochlin DL, Ganatra RH, Griffiths DF, 2002 Elastography in the detection of prostatic cancer. Clin Radiol 57: 1014-1020.
18. Itoh A, Ueno E, tohno E, et al, 2006 Breast disease: clinical application of US elastography for diagnosis. Radiology 239: 341-350.
19. Lyshchik A, Higashi T, Asato R, et al, 2007 Cervical lymph node metastases: diagnosis at sonoelastography -initial experience. Radiology 243: 258-267.
20. Tan SM, teh HS, Mancer JF, Poh WT, 2008 Improving B mode ultrasound evaluation of breast lesions with real-time ultrasound elastography--a clinical approach. Breast 17: 252-257.
21. Lyshchik A, Higashi T, Asato R, et al, 2005 Thyroid gland tumor diagnosis at US elastography. Radiology 237: 202-211.
22. Rago T, Santini F, Scutari M, Pinchera A, Vitti P, 2007 Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 92: 2917-2922.
23. Rago T, Di Coscio G, Basolo F, et al, 2007 Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (oxf) 66: 13-20.
24. Midiri M, Galia M, Runza G, et al, 2006 Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results. Eur Radiol 16: 2234-2241.
25. Quaia E, Calliada F, Bertolotto M, et al, 2004 Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232: 420-430.
26. Bartolotta TV, Midiri M, Quaia E, et al, 2005 Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 15: 685-693.
27. Bartolotta TV, Midiri M, Quaia E, et al, 2005 Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15: 1643-1649.
28. Schneider M, Arditi M, Barrau MB, et al, 1995 BRI: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbes. Invest Radiol 30: 451-457.
29. Schneider M, 1993 SonoVue, a new ultrasound contrast agent. Eur Radiol Suppl.3: S347-S348.
30. Albrecht, T, Blomley, M, Bolondi L, et al, 2004 Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 25: 249-256.
31. Layfield, LJ, Cibas, ES, Gharib H, et al, 2009 Thyroid aspiration cytology: current status. Ca Cancer J Clin 59: 99-110.
32. Baloch ZW, Cibas ES, Clark DP, et al, 2008 The National Cancer Institute thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 7: 5-6.
33. Cooper DS, Doherty GM, Haugen BR, et al, 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. thyroid 16: 109-142.
34. Ylagan LR, Farkas T, Dehner LP, 2004 Fine needle aspiration of the thyroid: a cytohistologic correlation and study of discrepant cases. thyroid 14: 35-41.
35. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK, 2002 Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 26: 41-44.
36. Redman R, Yoder BJ, Massoll NA, 2006 Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. thyroid 16: 1003-1008.
37. Zatelli MC, Trasforini G, Leoni S, et al, 2009 BRaF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol 161: 467-473.
38. Ríos, A, Manuel Rodríguez J, Balsalobre MD, Febrero B, Tébar J, Parrilla P, 2009 Distant metastases as the initial manifestation of follicular thyroid carcinoma. Endocrinol Nutr 56: 213-214.
39. Zafon C, Obiols G, 2009 The mitogen-activated protein kinase (MaPK) signaling pathway in papillary thyroid cancer. From the molecular bases to clinical practice. Endocrinol Nutr 56: 176-186.
40. Hernández, TM, Cuadro, AT, Fernández PY, et al, 2009 Usefulness of the determination of thyroglobulin in lymph node aspirates of patients with papillary thyroid carcinoma and positive antithyroglobulin antibodies. Endocrinol Nutr 56: 447-451.
41. Deandrea M, Mormile A, Veglio M, et al, 2002 Fine- needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract 8: 282-286.
42. Miltenburg DM, Prost HM, Graviss EA, et al, 2000 Role of frozen section, gender, age, and tumor size in the differentiation of follicular adenoma from carcinoma: a meta-analysis. Surgery 128: 1075-1081.
43. Yoon DY, Chang SK, Choi CS, et al, 2008 The prevalence and significance of incidental thyroid nodules identified on computed tomography. J Comput assist tomogr 32: 810-815.
44. Schraml C, Müssig K, Martirosian P, et al, 2009 Autoimmune thyroid disease: arterial spin-labeling perfusion MR imaging. Radiology 253: 435-442.
45. Schueller-Weidekamm C, Kaserer K, Schueller G, et al, 2009 Can quantitative diffusion-weighted MR imaging differentiate benign and malignant cold thyroid nodules? Initial results in 25 patients. Am J Neuroradiol 30: 417-422.
46. Dai G, Levy O, Carrasco N, 1996 Cloning and characterization of the thyroid iodine transporter. Nature 379: 458-460.
47. Spitzweg C, Morris JC, 2002 Sodium iodide symporter (NIS) and thyroid. Hormones (athens) 1: 22-34.
48. Meller J, Becker W, 2002 The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med 29:Suppl 2: 425-438.
49. Shen DHY, Kloos RT, Mazzaferri EL, et al, 2001 Sodium iodine symporter in health and disease. Thyroid 11: 415-425.
50. Pace L, Klain M, Albanese C, et al, 2006 Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. Eur J Nucl Med Mol Imaging 33: 179-183.
51. Rodrigues M, Li S, Gabriel M, Heute D, Greifeneder M, Virgolini I, 2006 99mtc-depreotide scintigraphy versus 18F-FDG-PEt in the diagnosis of radioiodine-negative thyroid cancer. J Clin Endocrinol Metab 91: 3997-4000.
52. Fletcher JW, Djulbegovic B, Soares HP, et al, 2008 Recommendations on the use of 18F-FDG PEt in oncology. J Nucl Med 49: 480-508.
53. Liu Y, 2009 Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. ann Nucl Med 23: 17-23.
54. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W, 1996 Fluorine-18-FDG and iodine-131 -iodide uptake in thyroid cancer. J Nucl Med 37: 1468-1472.
55. Wang W, Larson SM, Fazzari M, et al, 2000 Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85: 1107-1113.
56. Zoller M, Kohlfuerst S, Igerc I, et al, 2007 Combined PEt/Ct in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? Eur J Nucl Med Mol Imaging 34: 487-495.
57. Jentzen W, Freudenberg L, Eising EG, Sonnenschein W, Knust J, Bockisch A, 2008 optimized 124I PEt dosimetry protocol for radioiodine therapy of differentiated thyroid cancer. J Nucl Med 49: 1017-1023.
58. Lind P, Kohlfürst S, 2006 Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med 36: 194-205.